Want to see TSE:TELO full AI Analyst Report?
Total Valuation
Telo Genomics Corp has a market cap or net worth of C$5.02M. The enterprise value is C$5.86M.
Market CapC$5.02M
Enterprise ValueC$5.86M
Share Statistics
Telo Genomics Corp has 100,430,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding100,430,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Telo Genomics Corp’s return on equity (ROE) is 1.46 and return on invested capital (ROIC) is 1560.71%.
Return on Equity (ROE)1.46
Return on Assets (ROA)-3.85
Return on Invested Capital (ROIC)1560.71%
Return on Capital Employed (ROCE)1.42
Revenue Per Employee0.00
Profits Per Employee-288.84K
Employee Count8
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Telo Genomics Corp is ―. Telo Genomics Corp’s PEG ratio is 0.07.
PE Ratio―
PS Ratio0.00
PB Ratio-2.54
Price to FCF-2.49
Price to Operating Cash Flow-3.16
PEG Ratio0.07
Income Statement
In the last 12 months, Telo Genomics Corp had revenue of 0.00 and earned -2.31M in profits. Earnings per share was -0.02.
Revenue0.00
Gross Profit-86.56K
Operating Income-2.19M
Pretax Income-2.33M
Net Income-2.31M
EBITDA-2.10M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -1.59M and capital expenditures -18.76K, giving a free cash flow of -1.61M billion.
Operating Cash Flow-1.59M
Free Cash Flow-1.61M
Free Cash Flow per Share-0.02
Dividends & Yields
Telo Genomics Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.10
52-Week Price Change0.00%
50-Day Moving Average0.05
200-Day Moving Average0.05
Relative Strength Index (RSI)46.03
Average Volume (3m)68.96K
Important Dates
Telo Genomics Corp upcoming earnings date is Nov 19, 2026, TBA (Confirmed).
Last Earnings DateOct 28, 2026
Next Earnings DateNov 19, 2026
Ex-Dividend Date―
Financial Position
Telo Genomics Corp as a current ratio of 0.21, with Debt / Equity ratio of -91.20%
Current Ratio0.21
Quick Ratio0.21
Debt to Market Cap0.35
Net Debt to EBITDA-0.53
Interest Coverage Ratio-11.44
Taxes
In the past 12 months, Telo Genomics Corp has paid -15.38K in taxes.
Income Tax-15.38K
Effective Tax Rate<0.01
Enterprise Valuation
Telo Genomics Corp EV to EBITDA ratio is -2.44, with an EV/FCF ratio of -3.18.
EV to Sales0.00
EV to EBITDA-2.44
EV to Free Cash Flow-3.18
EV to Operating Cash Flow-3.22
Balance Sheet
Telo Genomics Corp has C$338.32K in cash and marketable securities with C$1.44M in debt, giving a net cash position of -C$1.11M billion.
Cash & Marketable SecuritiesC$338.32K
Total DebtC$1.44M
Net Cash-C$1.11M
Net Cash Per Share-C$0.01
Tangible Book Value Per Share-C$0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Telo Genomics Corp is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast25.57%